期刊文献+

进展期胃癌术后化疗效果与5-氟尿嘧啶通道基因的关系 被引量:2

Relationship between the fluorouracil pathway gene and effect of chemotherapy in advanced gastric cancer after surgery
原文传递
导出
摘要 目的研究进展期胃癌术后化疗效果与5-氟尿嘧啶(5-Fu)通道基因的关系。方法收集52例进展期胃癌术后辅助FOLFOX4化疗6个周期病例,建立数据库。选择5-Fu通道基因中的胸苷酸合成酶(TS)、二氢嘧啶脱氢酶(DPD)、乳清酸磷酸核糖转移酶(OPRT)3个基因,采用反转录聚合酶链反应(RT-PCR)方法检测52例胃癌组织和临近正常组织TS、DPD、OPRTmRNA表达,探讨5.Fu通道基因对化疗效果的影响。结果肿瘤组织中相对于GAPDH,TSmRNA相对表达量为0.92±0.28,较对应正常组织中的0.71±0.30高(t=3.730,P=0.001),胃癌组织和正常组织中OPRTmRNA呈正相关(r=0.45,P=0.001),Ts和DPDmRNA表达分别在肿瘤和正常组织中无相关性;肿瘤组织和正常组织中OPRT mRNA高表达者有较长生存期(t=3.036,P=0.003;t=2.713,P=0.009),肿瘤组织低DPD mRNA表达者有较长生存期(t=2.708,P=0.009),在正常组织中,高DPDmRNA表达者有较长生存期(t=2.616,P=0.012)。结论进展期胃癌术后化疗效果与DPD和OPRT相关,与TS的表达无关。 Objective To investigate the relationship between the fluorouracil pathway gene and effect of chemotherapy in advanced gastric cancer after surgery. Methods 52 postoperative patients with advanced gastric cancer using FOLFOX4 6-cycles combined chemotherapy were collected to set up the database. The expression of thymidine synthase(TS), dihydropyrimidine dehydrogenase(DPD) and orotate phosphoribosyltransferase(OPRT) in tumor tissue and adjacent non-tumor tissue of 52 patients with advanced gastric cancer were measured by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR). The influence of fluorouracil pathway gene on chemotherapy was investigated. Results The TS-mRNA level in tumor tissue was significantly higher than non-tumor tissue (0.92±0.28 vs 0.71±0.30) (t=3.730, P=0.001). OPRT-mRNA level in tumor tissue was positively correlated with the non-tumor tissue (r=0.45, P=0.001). No correlations were observed among other gene expressions. Patients whose high OPRT-mRNA gene expression in their tumors and non-tumor tissue showed an obviously better survival (t = 3.036, P =0.003; t = 2.713, P =0.009). Patients with low DPD-mRNA gene expression survived longer than those with high DPD-mRNA gene expression in tumor tissue with statistical signifieance(t = 2.708, P =0.009), whereas prolonged survival was observed in patients with high DPD-mRNA gene expression in non-tumor tissue (t = 2.616, P =0.012). Conclusion There is close relationships between chemotherapy in advanced gastric cancer and the expression of DPD-mRNA, OPRT-mRNA; while the expression of TS-mRNA have no relation with the survival time.
出处 《肿瘤研究与临床》 CAS 2011年第6期400-402,共3页 Cancer Research and Clinic
基金 内蒙古医学院附属医院重大科研基金(2004007)
关键词 胃肿瘤 抗肿瘤联合化疗方案 治疗结果 分子作用机制 Stomach neoplasms Antineoplastic combined chemotherapy protcols Treatmentoutcome Molecular mechanisms of action
  • 相关文献

参考文献2

二级参考文献18

  • 1Mackey JR, Jennings LL, Clarke ML, et al. Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers. Clin Cancer Res, 2002, 8: 110-116.
  • 2Miwa M, Ura M, Nishida M, et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5- fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancerm, 1998, 34: 1274-1281.
  • 3Ishikawa T, Sekiguchi F, Fukase Y, et al. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res, 1998, 58: 685-690.
  • 4Kikuyama S, Inada T, Shimizu K, et al. p53, bcl-2 and thymidine phosphorylase as predictive markers of chemotherapy in patients with advanced and recurrent gastric cancer. Anticancer Res, 2001, 21: 2149-2153.
  • 5Hata K, Fujiwaki R, Maede Y, et al. Expression of thymidine phosphorylase in epithelial ovarian cancer: correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity. Gynecol Oncol, 2000,77: 26-34.
  • 6Konno S, Takebayashi Y, Aiba M, et al. Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma. Cancer Lett, 2001, 166: 103-111.
  • 7Saito H, Tsujitani S, Oka S, et al. The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma. Br J Cancer, 1999, 81: 484-489.
  • 8Browder T, Butterfield CE, Kraling BM, et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res, 2000, 60: 1878-1886.
  • 9Salonga D, Danenberg KD, Johnson M, et al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase and thymidine phosphorylase. Clin Cancer Res, 2000, 6: 1322-1327.
  • 10Uchida K, Hayashi K, Kuramochi H, et al. Changes in intratumoral thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) mRNA expression in colorectal and gastric cancer during continuous tegafur infusion. Int J Oncol, 2001, 19: 341-346.

共引文献9

同被引文献35

  • 1Ikuko Miyazaki,Takashi Kawai,Youji Harada,Fuminori Moriyasu.A predictive factor for the response to S-1 plus cisplatin in gastric cancer[J].World Journal of Gastroenterology,2010,16(36):4575-4582. 被引量:8
  • 2徐皖湘,陈振东.二氢嘧啶脱氢酶活性在食管癌5-FU化疗中的应用价值[J].安徽医科大学学报,2007,42(1):84-86. 被引量:3
  • 3Park DJ, Lenz HJ. Determinants of chemosensitivity in gastric canc- er [ J ]. Curr Opin Pharmacol ,2006,6 (4) :337 - 344.
  • 4Li Q, Part D, Zhang JH, et al. Identification of the thymidylate syn- thase within the genome of white spot syndrome virus [ J]. Gcn Vir- ol, 2004,85 (7) :2035 - 2044.
  • 5Popat S, Matakidou A, Houlston RS. Thymidylate synthase expres- sion and prognosis in colorectal cancer: a systematic review and me- ta - analysis [ J ]. Clin Oncol,2004,22 ( 3 ) :529 - 536.
  • 6Marsh S, Collie DES, Li T, et al. Ethnic variarion in the thymidylate synrhase enhancer region polym orphism among Caucasian and Asi- an population [J]. Genomics,1999,58(3) :310 -312.
  • 7Mandola MV,Stcehlmacher J,Zhang W,et al. A 6bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS Mrna levels [ J ]. Phar- macogenetics,2004,14 (5) :319 - 327.
  • 8Merkelbach BS, Hans V, Marhiak M, et al. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidy|ate synthase mRNA and the microsatellite instability phe- notype of col.orectal cancer [J]. Oncol Rep,2004,11(4) :839 - 843.
  • 9Anatori F, Di Paolo A, Del Tscca M, et al. Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase ex- pression in colorectal cancer and normal mueosa in patients [ J]. 2006,16( 11 ) :809 -816.
  • 10Chu E, Koeller DM, Johnston PG, et al. Regulation of thymidylate synthase in human colon cancer cells treated with 5 - fluorouracil and interferon - gamma [ J ]. Mol Pharmacol, 1992,43 ( 4 ) : 527 - 533.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部